Neoclease

Neoclease is at the forefront of advancing gene editing technologies with a mission to transform healthcare by curing genetic diseases rather than just treating them. Utilizing a bespoke approach, the company develops tailored nucleases designed to target specific diseases or genes. Their innovative strategy combines synthetic biology techniques with generative AI to enhance precision, specificity, and minimize side effects in genetic therapies. Neoclease emphasizes collaboration, working with industry leaders and researchers to push the boundaries of what`s possible in gene editing. This cooperation aims to unlock new potentials in treating over 6,000 monogenic diseases by creating customized, effective treatments. By leveraging cutting-edge technology, Neoclease aims to establish gene editing as a cornerstone of precision medicine, ultimately aiming to rewrite genetics to overcome the root causes of various diseases.